536 related articles for article (PubMed ID: 23720168)
1. Polyethylenimines for siRNA and miRNA delivery in vivo.
Höbel S; Aigner A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
[TBL] [Abstract][Full Text] [Related]
2. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
3. Polyethylenimine (PEI)/siRNA-mediated gene knockdown in vitro and in vivo.
Höbel S; Aigner A
Methods Mol Biol; 2010; 623():283-97. PubMed ID: 20217558
[TBL] [Abstract][Full Text] [Related]
4. Polymer-based delivery of RNA-based therapeutics in ovarian cancer.
Weirauch U; Gutsch D; Höbel S; Aigner A
Methods Mol Biol; 2013; 1049():443-65. PubMed ID: 23913237
[TBL] [Abstract][Full Text] [Related]
5. Polyethylenimine PEI F25-LMW allows the long-term storage of frozen complexes as fully active reagents in siRNA-mediated gene targeting and DNA delivery.
Höbel S; Prinz R; Malek A; Urban-Klein B; Sitterberg J; Bakowsky U; Czubayko F; Aigner A
Eur J Pharm Biopharm; 2008 Sep; 70(1):29-41. PubMed ID: 18499413
[TBL] [Abstract][Full Text] [Related]
6. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
[TBL] [Abstract][Full Text] [Related]
7. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
[TBL] [Abstract][Full Text] [Related]
8. Cationic Lipid-Coated Polyplexes (Lipopolyplexes) for DNA and Small RNA Delivery.
Ewe A; Aigner A
Methods Mol Biol; 2016; 1445():187-200. PubMed ID: 27436320
[TBL] [Abstract][Full Text] [Related]
9. A low molecular weight fraction of polyethylenimine (PEI) displays increased transfection efficiency of DNA and siRNA in fresh or lyophilized complexes.
Werth S; Urban-Klein B; Dai L; Höbel S; Grzelinski M; Bakowsky U; Czubayko F; Aigner A
J Control Release; 2006 May; 112(2):257-70. PubMed ID: 16574264
[TBL] [Abstract][Full Text] [Related]
10. Recent developments in nucleic acid delivery with polyethylenimines.
Neuberg P; Kichler A
Adv Genet; 2014; 88():263-88. PubMed ID: 25409609
[TBL] [Abstract][Full Text] [Related]
11. Biocompatibility and efficacy of oligomaltose-grafted poly(ethylene imine)s (OM-PEIs) for in vivo gene delivery.
Gutsch D; Appelhans D; Höbel S; Voit B; Aigner A
Mol Pharm; 2013 Dec; 10(12):4666-75. PubMed ID: 24175860
[TBL] [Abstract][Full Text] [Related]
12. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
[TBL] [Abstract][Full Text] [Related]
13. Liposome-polyethylenimine complexes for enhanced DNA and siRNA delivery.
Schäfer J; Höbel S; Bakowsky U; Aigner A
Biomaterials; 2010 Sep; 31(26):6892-900. PubMed ID: 20561681
[TBL] [Abstract][Full Text] [Related]
14. Tyrosine-modified linear PEIs for highly efficacious and biocompatible siRNA delivery in vitro and in vivo.
Karimov M; Schulz M; Kahl T; Noske S; Kubczak M; Gockel I; Thieme R; Büch T; Reinert A; Ionov M; Bryszewska M; Franke H; Krügel U; Ewe A; Aigner A
Nanomedicine; 2021 Aug; 36():102403. PubMed ID: 33932594
[TBL] [Abstract][Full Text] [Related]
15. Unique Surface Modification of Silica Nanoparticles with Polyethylenimine (PEI) for siRNA Delivery Using Cerium Cation Coordination Chemistry.
Kapilov-Buchman Y; Lellouche E; Michaeli S; Lellouche JP
Bioconjug Chem; 2015 May; 26(5):880-9. PubMed ID: 25830668
[TBL] [Abstract][Full Text] [Related]
16. Polyethylenimine: A versatile, multifunctional non-viral vector for nucleic acid delivery.
Pandey AP; Sawant KK
Mater Sci Eng C Mater Biol Appl; 2016 Nov; 68():904-918. PubMed ID: 27524093
[TBL] [Abstract][Full Text] [Related]
17. Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs.
Aigner A
J Biotechnol; 2006 Jun; 124(1):12-25. PubMed ID: 16413079
[TBL] [Abstract][Full Text] [Related]
18. Selective blocking of primary amines in branched polyethylenimine with biocompatible ligand alleviates cytotoxicity and augments gene delivery efficacy in mammalian cells.
Tripathi SK; Gupta N; Mahato M; Gupta KC; Kumar P
Colloids Surf B Biointerfaces; 2014 Mar; 115():79-85. PubMed ID: 24333556
[TBL] [Abstract][Full Text] [Related]
19. Unmodified and tyrosine-modified polyethylenimines as potential carriers for siRNA: Biophysical characterization and toxicity.
Kubczak M; Michlewska S; Karimov M; Ewe A; Noske S; Aigner A; Bryszewska M; Ionov M
Int J Pharm; 2022 Feb; 614():121468. PubMed ID: 35031413
[TBL] [Abstract][Full Text] [Related]
20. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo.
Zhupanyn P; Ewe A; Büch T; Malek A; Rademacher P; Müller C; Reinert A; Jaimes Y; Aigner A
J Control Release; 2020 Mar; 319():63-76. PubMed ID: 31866504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
